Gi Mikawa

Biography

Prior to joining Nemesis Bioscience, Gi was Principal Scientific Officer and a key early member of the team that created Population Genetics Technologies where he developed a novel DNA tagging technology that was subsequently licensed to New England Biolabs. He also developed a variety of other technologies for DNA amplification via RNA and isolation of rare DNA variants from populations of DNA samples. Gi obtained his MD cum laude and PhD from the Jikei School of Medicine in Japan, and then joined the laboratory of Dr. Sydney Brenner in Cambridge, and at Lynx Therapeutics (later Illumina). Subsequently he worked at the Molecular Sciences Institute and the Scripps Research Institute. Gi developed bacteriophage lambda peptide display and revealed the molecular mechanism of transmission of signals of  the E.coli chemotaxis receptor tar;  he performed studies using genetically engineered bacteria and bacteriophage of membrane proteins and drug/receptor interactions.  

Research Interest

 Gi Mikawa has research interest in Population Genetics, Molecular Biology and Business Management.